Related Experiment Video
Updated: Jun 17, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Mesoporous silica nanoparticle-supported nanocarriers with enhanced drug loading, encapsulation stability, and
Jun Yong Oh1, Gyeongseok Yang1, Eunshil Choi1
1Department of Chemistry, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, Republic of Korea. echoi@unist.ac.kr.
Abstract:
For efficient drug delivery, stable encapsulation of a large amount of anticancer drugs is crucial, not to mention cell-specific delivery. Among many possible nanocarriers, mesoporous silica nanoparticles are versatile frameworks that satisfy those requirements owing to their characteristic internal pores with a large surface area and a tunable surface composition. By using a noncovalent post-modification strategy, MSN-based drug delivery systems with enhanced therapeutic efficiency can be prepared in a simple one-pot process by loading small anticancer drugs in the unmodified mesopores and by subsequently blocking the drug-loaded pores with a stimuli-responsive polymer gatekeeper. For targeted delivery, drug-loaded MSNs can be functionalized with suitable targeting components such as targeting ligands or artificial protein corona. This mini-review highlights the recent research in which MSN-supported nanocarriers are designed, synthesized, and characterized to possess a high drug loading capacity and encapsulation stability along with targeting capability for more efficient cancer treatment.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

